Ramucirumab - Wikipedia
Ramucirumab is a direct VEGFR2 antagonist, that binds with high affinity to the extracellular domain of VEGFR2 and block the binding of natural VEGFR ligands (VEGF-A, VEGF-C and VEGF-D). These ligands are secreted by solid tumors to promote angiogenesis (formation of new blood vessels from pre-existing ones) and enhance tumor blood supply.
Ramucirumab - NCI - National Cancer Institute
Non-small cell lung cancer that has metastasized. It is used: With erlotinib hydrochloride as first-line therapy in patients whose disease has certain mutations in the EGFR gene. With docetaxel in patients whose disease has gotten worse …
CYRAMZA® (ramucirumab) | VEGFR2 Inhibitor
CYRAMZA® is approved for the treatment of patients with advanced or metastatic stomach or gastroesophageal (GE) junction cancer, metastatic NSCLC, metastatic CRC, and AFP-High liver cancer (HCC).
Ramucirumab Uses, Side Effects & Warnings - Drugs.com
Ramucirumab is used to treat stomach cancer, colorectal cancer, or non-small cell lung cancer that has spread to other parts of the body. Ramucirumab may be given alone or in combination with other cancer medicines. Ramucirumab is usually given after other treatments have failed.
Ramucirumab: Uses, Interactions, Mechanism of Action
2007年11月18日 · Ramucirumab is an antineoplastic agent and direct VEGFR2 (vascular endothelial growth factor receptor 2) antagonist that blocks the binding of natural VEGF ligands, which are secreted by solid tumors to promote angiogenesis and enhance tumor blood supply.
Ramucirumab - Chemocare
RAMUCIRUMAB (ra mue SIR ue mab) treats some types of cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
Ramucirumab (Cyramza) Injection: Uses & Side Effects
Ramucirumab is a medication that treats stomach cancer, colorectal cancer, liver cancer and lung cancer. A healthcare provider will give you this injection via infusion in a hospital or clinic setting. The brand name of ramucirumab is Cyramza®.
Cyramza: Uses, Dosage & Side Effects - Drugs.com
2023年12月27日 · Cyramza (ramucirumab) is used to treat gastric cancer, non-small cell lung cancer, colorectal cancer, and hepatocellular carcinoma. Includes Cyramza side effects, interactions and indications.
Ramucirumab (intravenous route) - Mayo Clinic
2024年2月1日 · Descriptions. Ramucirumab injection is used alone or together with paclitaxel to treat advanced or metastatic (cancer that has already spread) stomach or gastroesophageal junction cancer (GEJ) after a patient has received other cancer medicines (eg, medicines that containing fluoropyrimidine or platinum) but did not work well.
Ramucirumab - Memorial Sloan Kettering Cancer Center
2022年12月12日 · Last Updated. Monday, December 12, 2022. This information from Lexicomp® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider.